- Malcolm R Macleod, specialist registrar, neurology (malcolm@apoptosis.freeserve.co.uk),
- Shah Ebrahim, professor of epidemiology of ageing,
- Ian Roberts, professor
- Western General Hospital, Edinburgh EH4 2XU
- Department of Social Medicine, University of Bristol, Bristol BS8 2PR
- Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT
EDITOR—We agree with Lemon and Dunnett that better methods of surveying the literature on animal experiments are needed,1 but we do not share their confidence in the utility of non-systematic reviews.
In clinical trials, systematic review and meta-analysis have made important contributions to our understanding of sources of bias, and the quality of clinical trials has improved as a result. We …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Ethical considerations
Published 14 February 2012
Re: Diagnosis and management of Raynaud’s phenomenon
Published 14 February 2012
Re: Raised inflammatory markers
Published 14 February 2012
Re: Physical activity for cancer survivors: meta-analysis of randomised controlled trials
Published 14 February 2012
Smokefree cars in Wales: Laws are better
Published 14 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (8 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (8 responses)
Published 1 Feb 2012
How much of a social media profile can doctors have? (7 responses)
Published 23 Jan 2012